Capiton's KD Pharma sale shelved on valuation challenges


A dual-track sale of Capiton-backed German omega-3 fatty acid manufacturer KD Pharma has been shelved, according to three sources familiar with the matter.



Source link

Leave a Reply

Your email address will not be published.